Rayence Co., Ltd.
Financials
Valuation Metrics
Rayence Co., Ltd.'s Market Cap is ₩1284B. At end of 2025 it was ₩863B. Ranked #1062 of 2,405 in KR market (top 44%), #544 of 1,627 on KOSDAQ (top 33%), #38 of 94 in Health Care Equipment & Services (top 40%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 128.41B KRW | KR#1,062/2,405 Sec#38/94 |
| Revenue | 131.69B KRW | KR#1,257/2,405 Sec#20/94 |
| Net Income | 4.14B KRW | KR#1,272/2,405 Sec#41/94 |
| Total Assets | 271.97B KRW | KR#1,097/2,405 Sec#26/94 |
| Net Assets | 242.10B KRW | KR#841/2,405 Sec#20/94 |
| Employees | 230 | KR#991/2,405 Sec#29/94 |
| Value | ||
| P/E | 31.05x | KR#1,336/2,405 Sec#44/94 |
| P/B | 0.53x | KR#929/2,405 Sec#13/94 |
| P/S | 0.98x | KR#1,420/2,405 Sec#25/94 |
| EV/EBITDA | 21.03x | KR#1,068/2,405 Sec#36/94 |
| FCF Yield | 5.56% | KR#849/2,405 Sec#21/94 |
| Profitability | ||
| ROE | 1.71% | KR#1,431/2,405 Sec#48/94 |
| ROA | 1.52% | KR#1,307/2,405 Sec#48/94 |
| Op. Margin | 3.18% | KR#1,222/2,405 Sec#46/94 |
| Revenue Growth | 16.40% | KR#638/2,405 Sec#36/94 |
| Financial Health | ||
| Debt Ratio | 12.34% | KR#191/2,405 Sec#11/94 |
| Total Debt | 774.0M KRW | KR#1,975/2,405 Sec#77/94 |
| FCF | 7.14B KRW | KR#808/2,405 Sec#21/94 |
| Cash | 41.16B KRW | KR#833/2,405 Sec#18/94 |
| Current Ratio | 11.99x | KR#74/2,405 Sec#9/94 |
| Net Debt/EBITDA | -9.65x | KR#45/2,405 Sec#1/94 |
| Dividend | ||
| Div. Yield | 3.86% | KR#509/2,405 Sec#6/94 |
| Div. Growth | 200.00% | KR#46/2,405 Sec#4/94 |
| Performance | ||
| 1Y Return | 40.98% | KR#200/2,405 Sec#6/94 |
| 1M Return | -10.10% | KR#1,177/2,405 Sec#46/94 |
| From 52W High | -11.54% | KR#57/2,405 Sec#2/94 |
| 1Y MDD | -21.32% | KR#82/2,405 Sec#4/94 |
| Trading | ||
| Volume | 18,185 shares | KR#1,545/2,405 Sec#59/94 |
| Trading Value | 138.8M KRW | KR#1,298/2,405 Sec#50/94 |
| Foreign Own. | 3.51% | KR#1,148/2,405 Sec#38/94 |
| Per Share | ||
| EPS | 249 KRW | KR#1,227/2,405 Sec#37/94 |
| BPS | 14,592 KRW | KR#719/2,405 Sec#10/94 |
Company Info
RAYENCE was established in 2011 following the spin-off of its DR business division, and holds several subsidiaries including OSKO MEX and Woori-en Co., Ltd. The company manufactures and sells digital X-ray detectors for medical, dental, veterinary, and industrial applications, and has developed flexible products using CMOS detector technology. RAYENCE leads the market through X-ray Imaging Solutions, expands into the veterinary medical market via its subsidiaries, and broadens its product lineup with new product launches. It is headquartered in Hwaseong-si, Gyeonggi-do.